Cite
APA Citation
Senkus-Konefka, E., Domchek, S., Im, S., Xu, B., Armstrong, A., Masuda, N., Delaloge, S., Li, W., Tung, N., Conte, P., Wu, W., Goessl, C., Runswick, S., & Robson, M. (n.d.). subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD. European journal of cancer, 92, S19–S20. http://access.bl.uk/ark:/81055/vdc_100060771599.0x000031